在teprotumumab治疗后甲状腺眼病的复发与反弹:回顾案例系列
Julie M Shabto1, Amy Shteyman1, Shanlee Stevens1
1Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University.
Ophthalmic plastic and reconstructive surgery
|February 20, 2026
概括
在teprotumumab治疗后,甲状腺眼病复发在活性阶段治疗的患者中比稳定阶段治疗的患者更严重和更长时间. 这表明,根据其活性,teprotumumab可能会以不同的方式调节疾病.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 甲状腺眼病 (TED) 是一种使人虚弱的自身免疫性疾病.
- 泰波穆马布是一种新的生物疗法,用于活跃的TED.
- 了解治疗后复发模式对于患者管理至关重要.
研究的目的:
- 为了比较TED复发后teprotumumab的临床特征.
- 根据治疗开始时的疾病阶段 (活跃与稳定) 来分析复发的时间和持续时间.
主要方法:
- 追溯26名成年患者的病例系列.
- 根据TED阶段的分层 (活性与稳定) 在teprotumumab启动时.
- 对复发特征的分析,包括proptosis和运动性缺陷.
主要成果:
- 活期患者的复发时间明显较早 (8.2 vs. 12.3 个月),复发时间较长 (11.1 vs. 4.2 个月).
- 活动期复发包括临床进展和视神经病变;稳定期复发恢复到基线.
- 两组之间不良事件的发生率相似.
结论:
- 根据治疗开始时的疾病阶段,teprotumumab后的TED复发不同.
- 活期复发较早,较长,更严重,表明疾病的调节.
- 稳定阶段复发可能代表一个独特的"反弹"现象,需要阶段特定的护理.
相关概念视频
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

